(Q80694712)

English

Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients

scientific article published on 30 July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Akhtar S

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

El Weshi A

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Abdelsalam M

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Hussaini H

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Janabi I

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Rahal M

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Maghfoor I

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

30 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

40

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

651-658

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17660837%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705792

0 references

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705792

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80694712&oldid=2125056550"